Loading...
Bangkok Dusit Medical Services Public Company Limited
BDULF•PNK
Healthcare
Medical - Care Facilities
$0.62
$0.00(0.00%)
Bangkok Dusit Medical Services Public Company Limited (BDULF) Financial Performance & Statements
Review Bangkok Dusit Medical Services Public Company Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.96%
↑ 6.96%
Operating Income Growth
8.33%
↑ 8.33%
Net Income Growth
11.21%
↑ 11.21%
Operating Cash Flow Growth
10.49%
↑ 10.49%
Operating Margin
18.71%
↑ 18.71%
Gross Margin
36.89%
↑ 36.89%
Net Profit Margin
14.82%
↑ 14.82%
ROE
16.26%
↑ 16.26%
ROIC
15.59%
↑ 15.59%
Bangkok Dusit Medical Services Public Company Limited (BDULF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Bangkok Dusit Medical Services Public Company Limited stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $27.40B | $28.15B | $25.70B | $26.61B |
| Cost of Revenue | $17.04B | $17.63B | $16.66B | $16.74B |
| Gross Profit | $10.37B | $10.52B | $9.04B | $9.87B |
| Gross Profit Ratio | $0.38 | $0.37 | $0.35 | $0.37 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.48B | $5.31B | $5.15B | $4.89B |
| Operating Expenses | $5.04B | $4.91B | $4.77B | $4.89B |
| Total Costs & Expenses | $22.08B | $22.54B | $21.81B | $21.63B |
| Interest Income | $39.02M | $40.17M | $47.46M | $48.15M |
| Interest Expense | $107.87M | $102.42M | $110.56M | $112.54M |
| Depreciation & Amortization | $1.60B | $1.55B | $1.50B | $1.48B |
| EBITDA | $6.99B | $7.22B | $5.82B | $6.83B |
| EBITDA Ratio | $0.26 | $0.26 | $0.23 | $0.26 |
| Operating Income | $5.32B | $5.61B | $4.27B | $4.98B |
| Operating Income Ratio | $0.19 | $0.20 | $0.17 | $0.19 |
| Other Income/Expenses (Net) | -$43.68M | -$38.33M | -$49.05M | -$64.39M |
| Income Before Tax | $5.28B | $5.57B | $4.22B | $5.25B |
| Income Before Tax Ratio | $0.19 | $0.20 | $0.16 | $0.20 |
| Income Tax Expense | $840.60M | $1.15B | $756.08M | $1.04B |
| Net Income | $4.33B | $4.25B | $3.33B | $4.07B |
| Net Income Ratio | $0.16 | $0.15 | $0.13 | $0.15 |
| EPS | $0.27 | $0.27 | $0.21 | $0.26 |
| Diluted EPS | $0.27 | $0.27 | $0.21 | $0.26 |
| Weighted Avg Shares Outstanding | $15.89B | $15.89B | $15.89B | $15.89B |
| Weighted Avg Shares Outstanding (Diluted) | $15.89B | $15.89B | $15.89B | $15.89B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan